JOHN E. DONELLO,MICHAEL E. GARST,RICHARD L. BEARD,THONG VU,VEENA VISWANATH,VIDYASAGAR VULIGONDA
申请号：
BR112014011316
公开号：
BR112014011316A2
申请日:
2012.11.10
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract of the disclosure the present invention relates to novel 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals modulators of the n-formyl peptide receptor-like 1 (fprl-1) receptor. 18945 pct (ap) Abstract Summary: "2,5-dioxoimidazolidin-1-yl-3-phenylurea derivative as peptide receptor receptor modulators as formyl-1 (fprl-1)". The present invention relates to novel 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as pharmaceutical modulators of the peptide receptor receptor as formyl. 1 (fprl-1).abstract of the disclosure the present invention relates to novel 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the n-formyl peptide receptor like-1 (fprl-1) receptor. 18945 pct (ap) tradução do resumo resumo patente de invenção: "derivado de 2,5-dioxoimidazolidin-1-il-3-feniluréia como moduladores do receptor de receptor do peptídeo como formil-1 (fprl-1)". a presente invenção refere-se aos novos derivados de 2,5-dioxoimidazolidin-1-il-3-feniluréia, processos para a sua preparação, composições farmacêuticas contendo-os e seu uso como moduladores farmacêuticos do receptor de receptor do peptídeo como formil-1 (fprl-1).
